PAR 4.17% 23.0¢ paradigm biopharmaceuticals limited..

PAR Investor Meeting - Questions from HC, page-58

  1. 2,150 Posts.
    lightbulb Created with Sketch. 581
    This worked out well.

    No clarity on peer review, patents, TGA Provisional Approval, lack of public KOL endorsement, lack of institutional investment, if they will guzump all the timelines to push for a DMOAD label before NDA whilst there is absolutely no clear pathway.

    I could say I told you so, so I will.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.0¢
Change
-0.010(4.17%)
Mkt cap ! $80.48M
Open High Low Value Volume
25.0¢ 25.0¢ 22.5¢ $167.1K 714.6K

Buyers (Bids)

No. Vol. Price($)
8 120730 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 49999 1
View Market Depth
Last trade - 16.10pm 18/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.